Indeed, the treatment of Il22−/− mice with rIFN-γ (1 μg) reduced yeast replication in the lung parenchyma (Figure 6E,G) with no effect on lung inflammation (Figure 6D,G) observed at seven days post-infection. This evidence concerns the gene IL22 and infection.